Document is current

Any future updates will be listed below

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

Crossref DOI link: https://doi.org/10.1007/s00198-015-3175-1

Published Online: 2015-05-23

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark